Dermata Therapeutics Inc

NASDAQ:DRMA   3:59:47 PM EDT
0.34
0.00 (+0.76%)
5:00:40 PM EDT: $0.36 +0.01 (+4.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Dermata Therapeutics Inc Stock, NASDAQ:DRMA

3525 Del Mar Heights Road, Suite 322, San Diego, California 92130
United States of America
Phone: +1.858.800.2543
Number of Employees: 8

Description

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.